CytomX Therapeutics, Inc.CTMXNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-25.45%
↑ 81% vs avg
Percentile
P83
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-135.90%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -25.45% | -231.3% |
| 2024 | 19.38% | +555.2% |
| 2023 | -4.26% | +97.7% |
| 2022 | -186.02% | +38.8% |
| 2021 | -303.75% | -166.6% |
| 2020 | -113.94% | +34.5% |
| 2019 | -174.05% | -36.3% |
| 2018 | -127.71% | -118.0% |
| 2017 | -58.59% | +84.8% |
| 2016 | -384.58% | - |